Analgesic switching in chronic users of dextropropoxyphene in France.

Amélie DaveluyMichael Charles BryanGhada Miremont-SalaméRégis LassalleClémentine LacueilleAngela GrelaudMarie FlocciaFrançoise HaramburuMaryse Lapeyre Mestre Joëlle Micallef Francesco Salvo

Published in: Fundamental & clinical pharmacology (2023)

Eighteen months after DXP/P withdrawal, more than 10% of patients stopped taking an analgesic. Vigilance is required regarding any change in analgesics by regularly reassessing patients' pain and, in the case of opioid treatments, by monitoring the risk of use disorders.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
neuropathic pain
prognostic factors
pain management
spinal cord injury